The Sentebiolab Senteligo™️ SARS-CoV-2 (COVID-19) Multiplex qPCR Detection Kit is an in vitro diagnostic test, based on real-time polymerase chain reaction technology. It tests for the presence or absence of ribonucleic acid (RNA) of SARS-CoV-2 coronavirus, specifically, in lower and upper respiratory tract samples from patients suspected of COVID-19 viral infection.
The Sentebiolab Senteligo™️ SARS-CoV-2 (COVID-19) Multiplex qPCR Detection test includes a Primer-Probe set inside the Reaction Mix that contains primers and probes for human RNaseP and viral N1 and N2 regions. The internal control (primer/probe set for human RNaseP gene) is used to identify possible qPCR inhibition, confirm the integrity of the reagents, and verify the quality of RNA extraction from patient material. RNaseP primers and probes included in the kit recognize the human RNaseP gene. The primers and probes for viral N1 and N2 regions specifically identify two distinct regions on the nucleocapsid (N) gene of the SARS-CoV-2 virus. These primers and probes do not recognize the SARS-CoV virus, whose genetic structure is highly similar to SARS-CoV-2.
The Sentebiolab Senteligo™️ SARS-CoV-2 (COVID-19) Multiplex qPCR Detection test also includes a positive control, which is labelled as “Positive Control”. Positive Control is a synthetic DNA which contains the target regions of the N1, N2 and RNaseP genes that are amplified with the primer-probe sets included in this kit. The positive control is used to identify possible qPCR inhibition, and confirm the integrity of the reagents.